Atai Life Sciences N.V. (ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, has a couple of data readouts to watch in the coming months.First up is the topline data readout from a pivotal phase III trial of Compass Pathways' investigational psilocybin therapy COMP360 for treatment-resistant depression (TRD) in Spring of this year.Treatme...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.